KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer

Sekino Yohei; Oue Naohide; Shigematsu Yoshinori; Ishikawa Akira; Sakamoto Naoya; Sentani Kazuhiro; Teishima Jun; Matsubara Akio; Yasui Wataru

首页> 外文期刊>Urologic oncology >KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer

【24h】

KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer

机译：KIFC1诱导对多西紫杉醇的抗性，与前列腺癌患者的存活有关

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: Prostate cancer (PCa) is a common malignancy worldwide. Docetaxel has been an important treatment option for patients with metastatic castration-resistant prostate cancer (CRPC). However, nearly all patients with CRPC treated with docetaxel eventually become refractory. In the present study, we analyzed the expression and distribution of kinesin family member Cl (KIFC1) in human PCa by immunohistochemistry and examined the effect of inhibiting KIFC1 expression on docetaxel resistance.

机译：目的：前列腺癌（PCA）是全世界普遍的恶性肿瘤。多西紫杉醇是转移性阉割前列腺癌（CRPC）患者的重要治疗选择。然而，几乎所有患有多西紫杉醇治疗的CRPC患者最终都会变得难以忍受。在本研究中，我们通过免疫组织化学分析了Kinesin家族成员Cl（KIFC1）在人PCA中的表达和分布，并研究了抑制KIFC1表达对多西紫杉醇抗性的影响。

著录项

来源
《Urologic oncology》 |2017年第1期|共1页
作者
Sekino Yohei; Oue Naohide; Shigematsu Yoshinori; Ishikawa Akira; Sakamoto Naoya; Sentani Kazuhiro; Teishima Jun; Matsubara Akio; Yasui Wataru;
展开▼
作者单位

Hiroshima Univ Inst Biomed &

Hlth Sci Dept Mol Pathol Hiroshima Japan;

Hiroshima Univ Inst Biomed &

Hlth Sci Dept Mol Pathol Hiroshima Japan;

Hiroshima Univ Inst Biomed &

Hlth Sci Dept Mol Pathol Hiroshima Japan;

Hiroshima Univ Inst Biomed &

Hlth Sci Dept Mol Pathol Hiroshima Japan;

Hiroshima Univ Inst Biomed &

Hlth Sci Dept Mol Pathol Hiroshima Japan;

Hiroshima Univ Inst Biomed &

Hlth Sci Dept Mol Pathol Hiroshima Japan;

Hiroshima Univ Inst Biomed &

Hlth Sci Dept Urol Hiroshima Japan;

Hiroshima Univ Inst Biomed &

Hlth Sci Dept Urol Hiroshima Japan;

Hiroshima Univ Inst Biomed &

Hlth Sci Dept Mol Pathol Hiroshima Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
Prostate cancer; KIFC1; Cancer stem cells; Docetaxel;

机译：前列腺癌;KIFC1;癌症干细胞;多西紫杉醇;

相似文献

外文文献
中文文献
专利

1. KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer [J] . Sekino Yohei, Oue Naohide, Shigematsu Yoshinori, Urologic oncology . 2017,第1期

机译：KIFC1诱导对多西紫杉醇的抗性，与前列腺癌患者的存活有关
2. Re: The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer [J] . Ozgur Berat Cem The Journal of Urology . 2018,第5期

机译：Re：二甲双胍在多西红柿化疗过程中使用的疗效抗癌前列腺癌前列腺癌特异性和整体存活
3. Re: The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer Reply [J] . The Journal of Urology . 2018,第5期

机译：Re：二甲双胍在多西红柿化疗过程中使用的疗法癌症癌前列腺癌特异性和整体存活率抗议前列腺癌癌症答复
4. On Predicting Survival Opportunities for Prostate Cancer by COX Regression in PSU Patients Data [C] . Nattawut Thongpim, Chidchanok Choksuchat, Tanan Bejrananda, International Conference on Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology . 2020

机译：通过PSU患者数据中的COX回归预测前列腺癌的生存机会
5. Mechanism of Extracellular Matrix Induced Tumor Survival and Drug Resistance in Castration-Resistant Prostate Cancer [D] . Chaudhary, Pooja. 2019

机译：细胞外基质诱导肿瘤存活和抗阉割前列腺癌的耐药机制
6. KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer [O] . Yohei Sekino, Naohide Oue, Yuki Koike, 2019

机译：KIFC1抑制剂CW069诱导前列腺癌细胞凋亡并逆转对多西他赛的耐药性
7. Increased ABCC4 Expression Induced by ERRα Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer [O] . Houbao Huang, Jing Li, Jing Shen, 2020

机译：由于前列腺癌在前列腺癌中，ERRα诱导的ABCC4表达增加导致多西紫杉醇的抗病抗性

KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer

摘要

著录项

相似文献

相关主题

期刊订阅